EPTIS
BAM Logo

Thrombosis (F5, F2)

EPTIS factsheet 794298 | Last revision 2020-10-23 | URL: https://www.eptis.bam.de/pts794298 https://www.eptis.bam.de/pts794298

PT provider
PT provider RCPAQAP RCPAQAP
Based in Australia
Language(s) English
Remarks This module qualitatively assesses laboratory performance in the detection of Factor V Leiden and Prothrombin gene variants. What's new: MTHFR testing is no longer included.
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
1µg of purified DNA in TE pH 8.0 F2 gene variants Molecular genetic testing
F5 gene variants -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Yes
Regularly operated Yes (4 cases per survey /2 surveys)
Year of first operation
Contact details of the PT provider
Provider Contact person
RCPAQAP
Suite 201/8 Herbert Street
St Leonards, 2065
Australia

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Mr Rhys Judd
Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Email: rhys.judd@rcpaqap.com.au rhys.judd@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminita Antin. Ms Luminita Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21